Cardinal Health to acquire VIASYS Healthcare for $1.5bn
16 May 2007
Dublin, Ohio and Conshohocken, Penn., USA. Cardinal Health
is to take over VIASYS Healthcare for approximately $1.5 billion, including
the assumption of outstanding debt.
With 2006 revenue of $610 million,
VIASYS is a leader in respiratory care, developing and marketing systems for
critical care and diagnostic use. VIASYS is also a leader in neurological,
audio and vascular diagnostics, disposable medical products used in surgical
procedures and enteral feeding, orthopaedic implant manufacturing and
The acquisition will expand Cardinal Health's clinical
and medical product offerings for global, acute-care customers and, combined
with its complementary respiratory products business, will establish the
company as a leader in the more than $4 billion respiratory care market.
The acquisition will also provide a range of complementary products to
Cardinal Health's medical disposables business and will leverage its
integrated hospital selling organization in the U.S. Worldwide, VIASYS has
more than 7,000 hospital customers in 100 countries and generates 40 percent
of its revenue from customers outside the US, adding substantially to
Cardinal Health's international presence.
"VIASYS is a perfect strategic
fit with our mission to help providers make health care safer and offers
immediate revenue and earnings opportunities in key geographies worldwide,"
said R. Kerry Clark, chief executive officer of Cardinal Health. "With a
strong platform and excellent momentum in our Clinical and Medical Products
businesses, we think the timing is ideal to broaden our offering. We have
developed a process through our recent acquisitions — particularly Alaris —
that will serve as a model for the rapid integration and realization of
synergies with the VIASYS acquisition."